Literature DB >> 7706261

Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators.

M L Schmitz1, G Stelzer, H Altmann, M Meisterernst, P A Baeuerle.   

Abstract

We show that the transactivating COOH terminus of the p65 subunit of human transcription factor NF-kappa B directly binds the general transcription factors TFIIB and TATA-binding protein (TBP) in vitro. Interaction of p65 with TFIIB required the most COOH-terminal sequence repeat within TFIIB. A functional interaction of TFIIB with p65 was evident from assays in yeast cells. Cotransfection experiments in COS cells revealed that only overexpression of TBP was able to further stimulate p65-dependent transactivation of a reporter gene. The coexpression of neither TBP nor TFIIB was able to relieve squelching, indicating the involvement of additional factors in transactivation by p65. A cell-free assay using highly purified factors revealed a specific transcriptional stimulation through the COOH-terminal activation domain of NF-kappa B by at least one cofactor, PC1, isolated from HeLa cells. These data show that the potent acidic transactivation domains in the COOH terminus of p65 are able to functionally recruit various components of the basic transcription machinery as well as coactivators.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706261     DOI: 10.1074/jbc.270.13.7219

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  A new method for the selection of protein interactions in mammalian cells.

Authors:  E Rojo-Niersbach; D Morley; S Heck; N Lehming
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 2.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

Review 3.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

4.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.

Authors:  N E Wittekindt; K Hörtnagel; C Geltinger; A Polack
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

5.  Transcription regulation from a TATA and INR-less promoter: spatial segregation of promoter function.

Authors:  Anuja A George; Manish Sharma; Badri N Singh; Naresh C Sahoo; Kanury Vs Rao
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

6.  In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.

Authors:  Bryan D Griffin; Paul N Moynagh
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

7.  PI3K limits TNF-alpha production in CD16-activated monocytes.

Authors:  Phillip R Kramer; Vanessa Winger; Jayne Reuben
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

8.  Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.

Authors:  M Guermah; S Malik; R G Roeder
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

9.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

10.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.